TY - JOUR
T1 - The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of Research
AU - Walsh, Sharon L.
AU - Babalonis, Shanna
PY - 2017/1/1
Y1 - 2017/1/1
N2 - While opioids are very effective analgesics for treating acute pain, humans have struggled with opiate addiction for millenia. An opium abuse epidemic in the early 1900's led the US government to develop a systematic research infrastructure and scientific plan to produce new compounds with analgesic properties but without abuse liability. This review describes the techniques that were developed for testing in the human laboratory, including empirically derived outcome measures and required elements for human abuse potential assessment. The evaluation and characterization of semi-synthetic and synthetic opioids, including full mu opioid agonists, partial agonists and mixed agonist-antagonists, are described across several decades of research. Finally, the prescription opioid epidemic beginning in the 1990's in the US led to a resurgence in abuse potential evaluations, and the application of these methods to the study of novel abuse-deterrent formulations is discussed.
AB - While opioids are very effective analgesics for treating acute pain, humans have struggled with opiate addiction for millenia. An opium abuse epidemic in the early 1900's led the US government to develop a systematic research infrastructure and scientific plan to produce new compounds with analgesic properties but without abuse liability. This review describes the techniques that were developed for testing in the human laboratory, including empirically derived outcome measures and required elements for human abuse potential assessment. The evaluation and characterization of semi-synthetic and synthetic opioids, including full mu opioid agonists, partial agonists and mixed agonist-antagonists, are described across several decades of research. Finally, the prescription opioid epidemic beginning in the 1990's in the US led to a resurgence in abuse potential evaluations, and the application of these methods to the study of novel abuse-deterrent formulations is discussed.
KW - Abuse deterrence
KW - Abuse potential testing
KW - Atypical opioids
KW - Mixed agonist-antagonist
KW - Opioid abuse
KW - Opioid agonist
UR - http://www.scopus.com/inward/record.url?scp=85031664944&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85031664944&partnerID=8YFLogxK
U2 - 10.1007/7854_2016_448
DO - 10.1007/7854_2016_448
M3 - Review article
C2 - 27356522
AN - SCOPUS:85031664944
SN - 1866-3370
VL - 34
SP - 33
EP - 58
JO - Current Topics in Behavioral Neurosciences
JF - Current Topics in Behavioral Neurosciences
ER -